We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current RSLS market cap is 2.74M. The company's latest EPS is USD -15.9777 and P/E is -0.24.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.16M | 1.98M | 1.94M | 1.97M | 2.29M |
| Operating Income | -3.88M | -1.9M | -2.21M | -2.05M | -1.76M |
| Net Income | -3.53M | -1.7M | -2.19M | -1.6M | -1.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.28M | 1.59M | 13.6M | 11.24M | 8.68M |
| Operating Income | -23.23M | -10.64M | -27.75M | -45.82M | -15.42M |
| Net Income | -23.68M | -12.33M | -61.93M | -46.21M | -11.39M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.83M | 10.66M | 8.23M | 6.39M | 5.62M |
| Total Liabilities | 4.74M | 4M | 3.7M | 3.36M | 4.13M |
| Total Equity | 3.08M | 6.66M | 4.53M | 3.04M | 1.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.39M | 10.62M | 54.26M | 11.14M | 10.66M |
| Total Liabilities | 4.54M | 5.95M | 8.19M | 7.48M | 4M |
| Total Equity | 15.85M | 4.67M | 46.07M | 3.66M | 6.66M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.5M | -16.96M | -2.07M | -3.43M | -3.74M |
| Investing | -10k | -10k | N/A | N/A | N/A |
| Financing | 12.11M | 17.57M | N/A | 24k | 24k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.87M | -10.41M | -15.38M | -21.9M | -16.96M |
| Investing | 2.36M | -171k | 1.86M | -92k | -10k |
| Financing | 13.38M | 430k | 33.3M | 3.13M | 17.57M |
| Market Cap | 2.74M |
| Price to Earnings Ratio | -0.24 |
| Price to Sales Ratio | 0.32 |
| Price to Cash Ratio | 0.61 |
| Price to Book Ratio | 0.41 |
| Dividend Yield | - |
| Shares Outstanding | 712.68k |
| Average Volume (1 week) | 22.01k |
| Average Volume (1 Month) | 25.44k |
| 52 Week Change | -68.43% |
| 52 Week High | 29.00 |
| 52 Week Low | 3.61 |
| Spread (Intraday) | 0.36 (9.11%) |
| Company Name | ReShape Lifesciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.reshapelifesciences.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
